yy Sex and ethnicity modify the associations between individual and contextual socioeconomic indicators and ideal cardiovascular health: MESA study

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Autores
MCCLELLAND, Robyn L.
DIEZ-ROUX, Ana V.
SZKLO, Moyses
Citação
JOURNAL OF PUBLIC HEALTH, v.41, n.3, p.E237-E244, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Low socioeconomic status (SES) is associated with cardiovascular disease (CVD) risk, but its association with different markers of SES may be heterogeneous by sex and race/ethnicity. Methods We have examined the relationships of four SES markers (education, family income, occupation and neighborhood SES) to ideal cardiovascular health (ICH), an index formed by seven variables. A total of 6792 cohort participants from six regions in the USA: Baltimore City and Baltimore County, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; New York, NY; and St. Paul, MN of the Multi-Ethnic Study of Atherosclerosis (MESA) (52.8% women) were recruited at baseline (2000-2) and included in the present analysis. Results ICH was classified as poor, intermediate or ideal. Level of education was significantly and inversely associated with ICH in non-Hispanic White men and women, in Chinese-American and Hispanic American men and African-American women. Family income was inversely and significantly associated with poor ICH in African-American men only. Conclusions We conclude that the strength of the associations between some SES markers and ICH differ between sexes and race/ethnic groups.
Palavras-chave
chronic disease, ethnicity, socioeconomics factors
Referências
  1. Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532
  2. Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
  3. Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350
  4. Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113
  5. Boykin S, 2011, J HEALTH CARE POOR U, V22, P111, DOI 10.1353/hpu.2011.0001
  6. Brenner AB, 2015, SOC SCI MED, V145, P17, DOI 10.1016/j.socscimed.2015.09.030
  7. Charles LE, 2012, OCCUP ENVIRON MED, V69, P713, DOI 10.1136/oemed-2012-100665
  8. Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163
  9. CUSHMAN M, 1995, CLIN CHEM, V41, P264
  10. Fretts AM, 2014, DIABETES CARE, V37, P2240, DOI 10.2337/dc13-2267
  11. Fujishiro K, 2011, OCCUP ENVIRON MED, V68, P319, DOI 10.1136/oem.2010.055582
  12. Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092
  13. Joseph JJ, 2016, DIABETOLOGIA, V59, P1893, DOI 10.1007/s00125-016-4003-7
  14. Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
  15. Mujahid MS, 2008, EPIDEMIOLOGY, V19, P590, DOI 10.1097/EDE.0b013e3181772cb2
  16. RAMSEY M, 1991, J CLIN MONITOR, V7, P56, DOI 10.1007/BF01617900
  17. Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228
  18. Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205
  19. Schroder SL, 2016, INT J CARDIOL, V219, P70, DOI 10.1016/j.ijcard.2016.05.066
  20. Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547
  21. Szklo M, 2014, EPIDEMIOLOGY BEOYND